Jenny Zhang

Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model

T. Reynolds, S. Lagalwar, M. Ingram, 2017, PloS one.

Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective α4β2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders.

D. Kombo, A. Mazurov, J. Speake, 2012, Journal of medicinal chemistry.

α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats

J. Strachan, M. Quik, T. Bordia, 2013, Neuropharmacology.

Structure-activity studies of 7-heteroaryl-3-azabicyclo[3.3.1]non-6-enes: a novel class of highly potent nicotinic receptor ligands.

R. Lukas, S. R. Breining, B. Bhatti, 2012, Journal of medicinal chemistry.

Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease

M. Bencherif, E. Stachowiak, M. Stachowiak, 2013, Pharmacology Biochemistry and Behavior.

Diazaspirocyclic compounds as selective ligands for the α4β2 nicotinic acetylcholine receptor.

J. J. Farias, B. Bhatti, J. Strachan, 2012, Bioorganic & medicinal chemistry letters.